Matthew Long

Assistant Professor

The Ohio State University Wexner Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Matthew Long is an Assistant Professor at The Ohio State University Wexner Medical Center in the United States. His research focuses on immunology and respiratory diseases, particularly in relation to tuberculosis, SARS-CoV-2, and acute lung injury. Recent articles authored by Dr. Long explore immune responses to viral infections, the role of nutritional interventions, and the implications of CFTR modulation in cystic fibrosis.

Articles (9)

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Jean Charron

Professeur

Laval University

CANADA

View details

Samuel Speaks

Ohio State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthew Long

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

IFN-λ uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I IFN

Does increased CCL2-mediated immune cell recruitment during mucosal BCG vaccination provide superior protection against TB?

MAP2K2 Delays Recovery in Murine Models of Acute Lung Injury and Associates with ARDS Outcome

Pathogenesis of pneumonia and acute lung injury.

Interferon Lambda Signaling in Macrophages Is Necessary for the Antiviral Response to Influenza.

Evaluation of Nutritional Gel Supplementation in C57BL/6J Mice Infected with Mouse-Adapted Influenza A/PR/8/34 Virus.

CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis.

Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis.

Loss of C/EBPα in Chronic Cigarette Smoke Exposure: A SAD Day for COPD.

Collaborators (2)

Jean Charron

Samuel Speaks

Make your next move.